Future Prospects Of The Middle East And Asia Pacific Cell And Gene Therapy Market

https://www.coherentmarketinsights.com/market-insight/middle-east-and-asia-pacific-cell-and-gene-therapy-market-4981
Middle East and Asia Pacific Cell and Gene Therapy Market 



Market Overview:

Cell and gene therapies involve treatment methods that repair or replace defective genes or introduce new genes and cells into a patient's body to cure disease. These therapies provide long-lasting benefits for various incurable and life-threatening diseases.

Market Key Trends:

One of the major trends in the Middle East and Asia Pacific cell and gene therapy market is the increase in research and development activities. There has been significant development in the area of cell and gene therapy over the past few years. Various biotechnology companies and academic research institutes are conducting extensive research to develop innovative cell and gene therapy products for treating cancer, neurological disorders, cardiovascular diseases, and other conditions. This has increased the translational capabilities, thereby driving the market growth.

Segment Analysis
 
The Middle East and Asia Pacific cell and gene therapy market is segmented into application and technology. The application segment is further divided into oncology, cardiovascular diseases, neurological disorders, orthopedic disorders, and others. Among these, the oncology segment dominated in 2021 due to the increased prevalence of cancer and the growing focus on the development of cell-based therapies for cancer treatment.

The Middle East and Asia Pacific Cell and Gene Therapy Market Demand is estimated to be valued at US$ 2,616.8 Million in 2023 and is expected to exhibit a CAGR of 17.3% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.

Key Takeaways
The Middle East and Asia Pacific cell and gene therapy market is expected to witness high growth, exhibiting CAGR of 17.3% over the forecast period, due to increasing prevalence of chronic diseases and growing focus on development of advanced therapies.

Regional analysis
Among regions, Asia Pacific is expected to grow at the fastest rate due to rising healthcare expenditure, increasing collaborations between academic and research institutes, and supporting government initiatives for development of regenerative medicines. China dominates the Asia Pacific market due to presence of major market players and growing clinical research activities in the country.

Key players
Key players operating in the Middle East and Asia Pacific cell and gene therapy market are Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Bluebird Bio, Inc. (Celgene Corporation), Gene biotherapeutics, Sibiono GeneTech Co. Ltd., Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Biogen INC., Organogenesis, Inc., JCR Pharmaceuticals Co. Ltd, uniQure N.V., WuxiAppTec, Lonza, and Immuneel Therapeutics Pvt Ltd.


Comments

Post a Comment

Popular posts from this blog

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Image
Dairy Alternative Market Market Overview: Dairy alternative products are gaining significant popularity due to their numerous advantages. These products are plant-based, making them suitable for individuals with lactose intolerance or those following a vegan diet. They offer similar nutritional benefits as traditional dairy products such as milk, cheese, and yogurt, while also addressing concerns related to animal welfare and environmental sustainability. The growing demand for dairy alternative products among health-conscious consumers is driving market growth. Market Key Trends: One key trend observed in the dairy alternative market is the increasing preference for plant-based milk substitutes. Plant-based milk alternatives such as almond milk, soy milk, and oat milk, among others, are gaining traction among consumers as a healthier and more sustainable option compared to traditional dairy milk. These plant-based milk alternatives offer various benefits such as being lactose-free, c...
Read more

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries

Image
Antimicrobial Additives Market Antimicrobial additives are extensively used in a wide range of end-use industries such as healthcare, packaging, food and beverage, construction, and automotive. These additives help protect various materials from microorganisms such as bacteria, viruses, etc. Some key applications of antimicrobial additives include packaging of food, medical devices, fabrics, flooring, coatings, etc. The ongoing COVID-19 pandemic has further increased the importance of hygiene and sanitation, driving demand for antimicrobial materials from various sectors. The global Antimicrobial Additives Market is estimated to be valued at US$ 3.47 Bn in 2024 and is expected to exhibit a CAGR of 25.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key drivers of the market's growth is the rising demand for antimicrobial additives from the packaging industry. Packaging manufacturers ...
Read more

The Global Eosinophilic Esophagitis Market Growth Accelerated By Availability Of Targeted Treatment Options

Image
Eosinophilic Esophagitis Market Eosinophilic esophagitis is a chronic immune/antigen-mediated disease characterized by eosinophil infiltration of the esophageal epithelium resulting in symptoms such as dysphagia, food impaction, and abdominal pain. The disease is increasingly being recognized and requires long-term pharmacologic treatment with proton pump inhibitors or topical corticosteroids to eliminate clinical symptoms. The global Eosinophilic Esophagitis Market is estimated to be valued at US$ 245.92 million in 2023 and is expected to exhibit a CAGR of 7.1%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The availability of targeted treatment options is accelerating the growth of the Eosinophilic Esophagitis market over the forecast period. Traditionally, topical steroids were used in the treatment of Eosinophilic Esophagitis. However, they are associated with side-effects such as nephrotoxici...
Read more